^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    RSPO3 fusion

    i
    Entrez ID:
    84870
    Related biomarkers:
    Expression
    Apply
    A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours (NCT02521844)
    Phase 1
    EDDC (Experimental Drug Development Centre), A*...
    Active, not recruiting
    Last update posted :
    11/08/2023
    Initiation :
    10/01/2015
    Primary completion :
    02/01/2024
    Completion :
    05/01/2024
    RSPO2 • RSPO3
    |
    RSPO3 fusion
    |
    Keytruda (pembrolizumab) • ETC-159